alternatives to glp 1 agonists Promising New Science on Weight Loss Drug Targeting GLP-1, GIP & GCG
Description
Metabolic effects of glucagon in the Wistar Rat
Investigation of the haemodynamic effects of exenatide in healthy male subjects
These drugs can reduce obesity-related medical diseases, leading to fewer interventions
289 The rise in cAMP activates PKA, a versatile protein kinase that phosphorylates various target proteins
The risk of gastrointestinal adverse events is increased with GLP-1RA therapy but these effects tend to be mild-to-moderate and transient, and are not the reason for observed weight loss
Chetty AK et al
